Elagolix Sodium

Showing Topics 1 - 3 of 3

 Elagolix Sodium

Elagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist (GnRH antagonist) medication which is used in the treatment of pain associated with endometriosis in women.[1][5][6][4][2][7][8] It is also under development for the treatment of uterine fibroids and heavy menstrual bleeding in women.[8] The medication was under investigation...
 NDC 0074-0038
Orilissa 150 mg Oral Tablet, Film Coated by Abbvie Inc. ## Package Codes: 0074-0038-01, 0074-0038-07, 0074-0038-28 ## Active Ingredients: Elagolix Sodium
 NDC 0074-0039
Orilissa 200 mg Oral Tablet, Film Coated by Abbvie Inc. ## Package Codes: 0074-0039-01, 0074-0039-14, 0074-0039-56 ## Active Ingredients: Elagolix Sodium

Can't Find What You're Looking For? Submit a New Topic Below

No registration needed.
Simply fill out the form below.

What are the main keywords of your topic?



 Optional, stays hidden.
Get notified when a reply is posted here.

5) Text Verification: *
Prevents SPAM.

Click here to show the question

This form will be submitted securely


Discussion Thread Guidelines: Any participation in the discussion threads signifies your agreement with the Terms of Use and Privacy Policy. (1) Act civilized and be respectful towards others. No profanity, vulgarity or lewd / suggestive content is allowed. (2) Posts encouraging, facilitating, or seeking advice about the abuse of medications or other substances are prohibited. (3) Personal contact information (such as telephone numbers, email addresses, etc) is not allowed to appear on our discussion threads. (4) We do not allow our forums to be used for buying, selling, trading, or for the promotion of a product or service. (5) Posting external links to other web sites is not allowed without our prior approval. (6) We reserve the right to edit or remove content which we find objectionable to the community at our sole discretion.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA